N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms

Neill, Erica; Rossell, Susan L; Yolland, Caitlin; Meyer, Denny; Galletly, Cherrie; Harris, Anthony; Siskind, Dan; Berk, Michael; Bozaoglu, Kiymet; Dark, Frances; Dean, Olivia; Francis, Paul; Liu, Dennis; Phillipou, Andrea; Sarris, Jerome; Castle, David J

File(s) not publicly available

N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms

journal contribution

posted on 2022-09-29, 06:32 authored by Erica Neill, Susan L Rossell, Caitlin Yolland, Denny Meyer, Cherrie Galletly, Anthony Harris, Dan Siskind, Michael BerkMichael Berk, Kiymet Bozaoglu, Frances Dark, Olivia DeanOlivia Dean, Paul FrancisPaul Francis, Dennis Liu, Andrea Phillipou, Jerome Sarris, David J Castle

N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms

History

Journal

SCHIZOPHRENIA BULLETIN

Publisher

OXFORD UNIV PRESS

Publisher DOI

https://doi.org/10.1093/schbul/sbac065

ISSN

0586-7614

eISSN

1745-1701

Language

English

Author URL

https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000827769500001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a045e4b2bb1f2b747c68c720ec8913b7

File(s) not publicly available

N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms

History

Journal

Publisher

Publisher DOI

ISSN

eISSN

Language

Author URL

Usage metrics

Read the peer-reviewed publication

Categories

Keywords

Licence

Exports